Globular adiponectin expression in mouse models of obesity or atherosclerosis can ameliorate their detrimental cardiometabolic phenotypes by improving insulin sensitivity and inhibiting the progression of atherosclerotic lesions [200]. Here, ADIPOQ is linked to obesity disorder.